Biotechnology
TSVT
2.48
price down icon6.06%   -0.16
after-market Handel nachbörslich: 2.47 -0.010 -0.40%

2 Seventy Bio Inc (TSVT)
full-star
loading
Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt TSVT? Forum Prognose
Schlusskurs vom Vortag:
$2.64
Offen:
$2.57
24-Stunden-Volumen:
220.30K
Relative Volume:
0.70
Marktkapitalisierung:
$133.61M
Einnahmen:
$44.12M
Nettoeinkommen (Verlust:
$-156.25M
KGV:
-0.8078
EPS:
-3.07
Netto-Cashflow:
$-154.61M
1W Leistung:
-5.70%
1M Leistung:
-4.25%
6M Leistung:
-44.02%
1J Leistung:
-56.03%
1-Tages-Spanne:
Value
$2.455
$2.665
1-Wochen-Bereich:
Value
$2.398
$2.69
52-Wochen-Spanne:
Value
$2.29
$5.99

2 Seventy Bio Inc Stock (TSVT) Company Profile

Name
Firmenname
2 Seventy Bio Inc
Name
Sektor
Healthcare (1189)
Name
Branche
Biotechnology (682)
Name
Telefon
339-499-9300
Name
Adresse
60 BINNEY STREET, CAMBRIDGE
Name
Mitarbeiter
425
Name
Twitter
Name
Nächster Verdiensttermin
2024-12-12
Name
Neueste SEC-Einreichungen
Name
TSVT's Discussions on Twitter

Vergleichen Sie TSVT mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
TSVT
2 Seventy Bio Inc
 2.48 133.61M 44.12M -156.25M -154.61M -3.07
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
 483.31 124.35B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
 684.87 75.07B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
 622.61 37.96B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
 243.53 31.79B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
BNTX
Biontech Se Adr
 111.56 27.34B 3.30B -501.07M 1.03B -2.1146

2 Seventy Bio Inc Stock (TSVT) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2024-06-06 Herabstufung Goldman Neutral → Sell
2024-01-31 Hochstufung Leerink Partners Market Perform → Outperform
2024-01-31 Herabstufung TD Cowen Outperform → Market Perform
2023-10-30 Herabstufung Leerink Partners Outperform → Market Perform
2023-10-12 Eingeleitet Citigroup Buy
2023-09-13 Herabstufung Goldman Buy → Neutral
2023-09-12 Herabstufung Guggenheim Buy → Neutral
2023-07-28 Herabstufung Morgan Stanley Overweight → Equal-Weight
2022-10-31 Eingeleitet Guggenheim Buy
2022-05-02 Eingeleitet Goldman Buy
2022-02-10 Eingeleitet SVB Leerink Outperform
2022-01-06 Eingeleitet Cowen Outperform
2021-11-09 Eingeleitet Canaccord Genuity Buy
2021-11-08 Eingeleitet Morgan Stanley Overweight
2021-11-08 Eingeleitet Wedbush Outperform
Alle ansehen

2 Seventy Bio Inc Aktie (TSVT) Neueste Nachrichten

pulisher
02:18 AM

Layoff Tracker: CRISPR, Cytiva Laying Off Employees - BioSpace

02:18 AM
pulisher
Feb 16, 2025

Analysts Set 2seventy bio, Inc. (NASDAQ:TSVT) Target Price at $7.20 - Defense World

Feb 16, 2025
pulisher
Feb 06, 2025

2seventy bio Reports Preliminary* Full-Year U.S. Abecma Sales and Select Financial Results - Business Wire

Feb 06, 2025
pulisher
Feb 05, 2025

Gossamer Study Finds Seralutinib Has Long-Lasting Effects in PAH - Managed Healthcare Executive

Feb 05, 2025
pulisher
Jan 20, 2025

Weiss Ratings Reaffirms “Sell (E+)” Rating for 2seventy bio (NASDAQ:TSVT) - Defense World

Jan 20, 2025
pulisher
Jan 04, 2025

Barclays PLC Sells 132,019 Shares of 2seventy bio, Inc. (NASDAQ:TSVT) - Defense World

Jan 04, 2025
pulisher
Dec 18, 2024

Fmr LLC Has $701,000 Stock Holdings in 2seventy bio, Inc. (NASDAQ:TSVT) - Defense World

Dec 18, 2024
pulisher
Nov 15, 2024

Analysts Have Been Trimming Their 2seventy bio, Inc. (NASDAQ:TSVT) Price Target After Its Latest Report - Simply Wall St

Nov 15, 2024
pulisher
Nov 12, 2024

2seventy bio Reports Third Quarter Financial Results and Recent Operational Progress - Business Wire

Nov 12, 2024
pulisher
Nov 06, 2024

Barinthus Bio Reports Third Quarter 2024 Update on Corporate Developments and Financial Results - GlobeNewswire

Nov 06, 2024
pulisher
Nov 04, 2024

2seventy bio to Report Third Quarter 2024 Financial Results and Participate in Upcoming Investor Conference - Business Wire

Nov 04, 2024
pulisher
Oct 22, 2024

2seventy bio, Inc. (NASDAQ:TSVT) Shares Sold by Exchange Traded Concepts LLC - Defense World

Oct 22, 2024

Finanzdaten der 2 Seventy Bio Inc-Aktie (TSVT)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

2 Seventy Bio Inc-Aktie (TSVT) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
Snow Jessica
See Remarks
Jan 03 '25
Sale
2.94
1,000
2,936
152,479
Snow Jessica
See Remarks
Jan 07 '25
Sale
2.64
186
491
147,179
Leschly Nick
Director
Jan 03 '25
Sale
2.94
85,978
252,423
1,234,498
Leschly Nick
Director
Jan 06 '25
Sale
2.78
892
2,478
1,233,606
Eatwell Victoria
Chief Financial Officer
Jan 03 '25
Sale
2.94
1,013
2,974
339,076
Eatwell Victoria
Chief Financial Officer
Jan 06 '25
Sale
2.78
97
270
338,979
Baird William D III
President and CEO
Jan 03 '25
Sale
2.94
31,718
93,121
862,889
Baird William D III
President and CEO
Jan 06 '25
Sale
2.78
763
2,120
862,126
Snow Jessica
See Remarks
Dec 13 '24
Sale
3.23
2,287
7,393
153,479

Ähnlich wie TSVT

biotechnology INSM
$76.29
price down icon 6.45%
biotechnology GMAB
$22.96
price up icon 1.23%
biotechnology RPRX
$33.86
price up icon 0.65%
biotechnology SMMT
$19.13
price down icon 7.54%
biotechnology ONC
$245.53
price down icon 9.67%
biotechnology BNTX
$111.56
price down icon 1.20%
In Yahoo öffnen | In Google öffnen | In Finviz öffnen | In MarketWatch öffnen | Öffnen Sie in EDGAR | Offen in Reuters
Kapitalisierung:     |  Volumen (24h):